Astrazeneca

2 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

AstraZeneca and Ionis face market volatility following the failure of their heart disease drug, Wainua, in a critical clinical trial.

4 sources 4 articles v 10 2m ago

↓ Cooling Business

AstraZeneca and Ionis face a sharp market decline following the failure of a collaborative heart disease drug trial.

5 sources 5 articles v 3 1h ago